ClinicalTrials.gg
RecruitingNCT07522489Updated Aug 13, 2026

Imageless Navigation Versus Image-Based Navigation in Robotic-Assisted Total Knee Arthroplasty for Knee Osteoarthritis

An interventional study of Imageless Robotic-Assisted Total Knee Arthroplasty and Image-based Robotic-Assisted Total Knee Arthroplasty in Osteoarthritis (OA) of the Knee, Knee Pain Arthritis and Total Knee Arthroplasty (TKA), sponsored by Medical University of Warsaw. Recruiting at 1 site in Poland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-13.

Primary conditionOsteoarthritis, KneeRegistry: OsteoarthritisReclassifiedWhy we changed it
Registry
Osteoarthritis — the first condition term the registry derived for this study.
ClinicalTrials.gg
Osteoarthritis, Knee
Why
  1. The study's title name Osteoarthritis, Knee, a narrower term within Osteoarthritis.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Medical University of Warsaw · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Aug 2026; still recruiting 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
146
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 78 studies in Osteoarthritis, Knee with a site in Poland — 12 open to participants now, 13 under way, 2 of them phase 3. Osteoarthritis, Knee · Poland.

Planned enrollment
34th of 72
146 · median 115
Started
2026
with 9 others
No phase
28 of 78
9 open now
Primary completion
2029-01
later than 12 of 12 live
Registered
72nd of 78
by date
Lead sponsor
6 of 78
Medical University of Warsaw

Among the 78 studies in Osteoarthritis, Knee with a site in Poland, this one is the 34th largest by planned enrollment of the 72 interventional ones that give a count, is one of 10 that started in 2026, is one of 28 with no phase, reaches primary completion later than 12 of the 12 other live ones, and was the 72nd registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

12 of the 78 studies in Osteoarthritis, Knee with a site in Poland are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Poland have not opened yet or have stopped. Only those recruiting at a site in Poland →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 78 studies in Osteoarthritis, Knee with a site in Poland, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn if imageless navigation is not inferior to image-based navigation in robotic-assisted total knee arthroplasty (RA-TKA) for treating patients with knee osteoarthritis.

The main questions the study aims to answer are:

  1. Does imageless procedure provide functional results comparable to those of image-based navigation?
  2. Are there differences in postoperative complications patients may experience after RA-TKA with imageless and image-based navigation? Researchers will compare imageless navigation with image-based navigation used in total knee arthroplasty to assess whether imageless navigation is comparable for the treatment of knee osteoarthritis.

Participants will:

  1. Answer survey questions about knee pain and function before RA-TKA.
  2. Undergo RA-TKA with imageless navigation or image-based navigation.
  3. Visit the Clinic after 6 months and 12 months after surgery for checkups and to answer the same survey questions about postoperative knee pain and function.
Read the detailed description

The trial will include patients with end-stage osteoarthritis, qualified for Robotic-Assisted Total Knee Arthroplasty (RA-TKA). For each patient, a full-length standing radiograph will be taken with designated sensors. Based on these, a three-dimensional model of the knee joint will be generated, enabling preoperative planning and intraoperative navigation in the image-based mode. Patients who meet the criteria and provide informed consent will be included in the study. Immediately before surgery, patients will be randomly assigned by a computer programme to either the experimental or control group in a 1:1 ratio, remaining blinded to the chosen method. In the experimental group, RA-TKA will be performed using imageless navigation, whereas in the control group, it will be performed using image-based navigation. In both groups, the procedure will be performed by experienced specialists with several years of experience, according to a standardized protocol: a medial parapatellar approach with restricted kinematic alignment, using a medial congruent knee implant.

The total number of patients included in the study is planned to be 146, with 73 in the experimental group and 73 in the control group. The group size was calculated based on a power analysis; power level: 80%, significance level: α=0.05, minimal clinically important difference: 5 points on the Oxford Knee Score (OKS), standard deviation: 10 points on the OKS. The study's dropout rate is estimated at 15%.

Radiologic imaging, survey responses, and intraoperative records will be stored on physical disks and paper, as well as in a secure cloud-based database. All other records will be stored digitally only. Registry data will be compared with external data sources (medical records) every 6 months to assess their accuracy and completeness. A Linear Mixed-Effects Model will be used to account for correlation between OKS measurements in the same patient. Both Per-Protocol and Intention-to-Treat analyses will be reported. For comparing continuous variables, a t-test (if normally distributed) or a Mann-Whitney U test (if skewed) will be used. Categorical variables will be compared with Fisher's Exact Test or the Chi-squared test. A cost-minimization analysis will be conducted using economic data.

03

Conditions studied

  • Osteoarthritis (OA) of the Knee
  • Knee Pain Arthritis
  • Total Knee Arthroplasty (TKA)
  • Robotic Assisted Arthroplasty

Browse trials for

Keywords

  • Knee Osteoarthritis
  • Robotic-Assisted Total Knee Arthroplasty
  • Patient Reported Outcome Measures
  • Imageless Navigation
  • Image-based Navigation
04

In context

Osteoarthritis, Knee Reclassified

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

This study's planned enrollment of 146 is above the median of 68 across 2,719 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

Medical University of Warsaw is the lead sponsor of 327 studies on the registry; 88 are open to participants now.

Compared within Osteoarthritis, Knee, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Osteoarthritis. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Symptomatic, radiologically confirmed advanced osteoarthritis of the knee.
  2. Patients referred for primary robotic-assisted total knee arthroplasty.
  3. Patients in whom a correctly performed radiograph with designated sensors has confirmed the possibility of performing robotic-assisted total knee arthroplasty with image-based navigation.
  4. Patients capable of giving to participate in the study and willing to attend all follow-up visits.

Exclusion criteria

Exclusion Criteria:

  1. No for the surgery.
  2. No informed consent for taking part in the study.
  3. Pregnancy.
  4. Active infections.
  5. Diagnosed comorbidities: arthritis, malignant tumors, serious neurological disorders affecting a reliable functional outcome measurement (e.g., severe stroke, severe Parkinson's disease).
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
146 participants (estimated)

Study arms

  • Active comparator
    Imageless Robotic Navigation

    Procedure: Imageless Robotic-Assisted Total Knee Arthroplasty

  • Active comparator
    Image-based Robotic Navigation

    Procedure: Image-based Robotic-Assisted Total Knee Arthroplasty

Interventions

  • ProcedureImageless Robotic-Assisted Total Knee Arthroplasty

    Patients undergoing Robotic-Assisted Total Knee Arthroplasty with Imageless Navigation

  • ProcedureImage-based Robotic-Assisted Total Knee Arthroplasty

    Patients undergoing Robotic-Assisted Total Knee Arthroplasty with Image-based Navigation

07

What researchers measure

Primary outcomes

  1. Patient-Reported Outcome Measures assessed with the Oxford Knee Score

    Zero is equivalent to the worst possible function of the joint and 48 indicates the best achievable function.

    Time frame: Survey taken right before surgery, at 6 months, and at 12 months after surgery.

Secondary outcomes

  1. Range of motion

    Measured according to the neutral-zero method with a 360-degree goniometer.

    Time frame: On admission to the hospital, at 6 months, and at 12 months postoperatively.

  2. Number of Participants achieving a planned postoperative limb alignment

    The percentage of patients within ±3 degrees of the preoperative target.

    Time frame: From enrollment to 12 months after surgery.

  3. Postoperative radiographic results

    Hip-Knee-Ankle angle, mechanical axis deviation, coronal femoral component angle (mechanical lateral distal femoral angle, mechanical lateral proximal femoral angle), sagittal femoral tilt/flexion, coronal tibial component angle (mechanical/anatomical lateral distal tibial angle, mechanical/anatomical medial proximal tibial angle) posterior tibial slope, joint line convergence angle, all measured in degrees

    Time frame: From enrollment to 12 months after surgery.

  4. Postoperative pain assessed with a VAS scale

    Zero is equivalent to no pain and 10 indicates the worst possible pain.

    Time frame: Survey taken right before surgery, at 6 months, and at 12 months after surgery.

  5. Time of the surgical procedure

    Duration of the surgical procedure in total and for each stage measured in minutes.

    Time frame: From the beginning to the end of the surgical procedure.

  6. Estimation of perioperative blood loss

    Intra-operative blood loss estimation by measuring the blood volume accumulated in suction bottles in milliliters, taking into account the volume of saline solution used during the surgery.

    Time frame: Immediately after the end of the surgery.

  7. Difference between preoperative and postoperative hemoglobin levels

    Hemoglobin levels will be obtained from samples taken at different times before and after surgery.

    Time frame: Hemoglobin levels will be measured within 2 weeks before surgery, as well as 24, 48 and 72 hours after surgery.

  8. Postoperative complications

    The percentage of cases with reported postoperative complications, such as: bleeding, wound complication, thromboembolic disease, neural deficit, vascular injury, ligament injury, instability, malalignment, stiffness, periprosthetic joint infection, periprosthetic fracture, extensor mechanism disruption, dislocation, bearing surface wear, osteolysis, implant loosening, revision, death.

    Time frame: From enrollment to 12 months after surgery.

  9. Costs required for preoperative planning

    Costs of all preoperative imaging and procedures necessary to plan imageless and image-based robotic navigation.

    Time frame: From one month before enrollment to 12 months after surgery.

  10. Time required for preoperative planning

    Time required to prepare all preoperative imaging and procedures necessary to plan imageless and image-based robotic navigation.

    Time frame: From one month before enrollment to 12 months after surgery.

08

Study locations

1 of 1 sites recruiting
  • Department of Orthopedics and Locomotor Traumatology, Medical University of Warsaw
    Warsaw, Mazovian 02-005, Poland
    Recruiting
    • Paweł Kasprzak, MD · Contactpawel.kasprzak@wum.edu.pl · 22 50 21 514
    • Paweł Łęgosz, MD, Professor · Principal investigator
    • Łukasz Pulik, MD, PhD · Principal investigator
    • Paweł Kasprzak, MD · Principal investigator
09

References and documents

Individual participant data

Plan to share: Yes — De-identified study results will be disseminated in conference abstracts and peer-reviewed journal articles.

Supporting information: Study protocol, Statistical analysis plan

Time frame: Within 12 months of the trial completion.

Access criteria: Data and supporting information will be shared upon reasonable request to the Principal Investigator. After the Principal Investigator reviews and approves the applicant's request, de-identified information will be provided.

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Jan 2029, 29 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 29 months is above that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 30, 2026
First posted
Apr 13, 2026
StartActual
Aug 6, 2026
Primary completionEst.
Jan 2029
CompletionEst.
Jan 2029
Last update
Aug 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT07522489
Responsible party
Sponsor
First posted
Apr 13, 2026
Start date
Aug 6, 2026
Primary completion
Jan 2029 (estimated)
Completion
Jan 2029 (estimated)
Last update
Aug 13, 2026

Study contacts

Paweł Kasprzak, MD
Contact
pawel.kasprzak@wum.edu.pl
22 50 21 514 ext. +48
Paweł Łęgosz, MD, Professor
principal investigator · Medical University of Warsaw
Łukasz Pulik, MD, PhD
principal investigator · Medical University of Warsaw
Paweł Kasprzak, MD
principal investigator · Medical University of Warsaw

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion